Interaction reference

GLP-1 receptor agonists with Metformin

No significant pharmacokinetic interaction. Both medications routinely combined as the foundation of modern type 2 diabetes care.

Metformin + a GLP-1 is the most-prescribed combo in T2D care. Safe and synergistic.

Also known as: Glucophage, Glumetza, Fortamet

Per-GLP-1 breakdown

Wegovysemaglutide 2.4 mg
No documented interaction
Mechanism: Distinct mechanisms (metformin: hepatic glucose production + insulin sensitivity; GLP-1: glucose-dependent insulin secretion + satiety).
What to do: Standard pairing. Watch for additive GI side effects in the first 2 weeks; staggering doses 4+ hours apart helps. No dose adjustment needed.
Zepboundtirzepatide
No documented interaction
Mechanism: Distinct mechanisms (metformin: hepatic glucose production + insulin sensitivity; GLP-1: glucose-dependent insulin secretion + satiety).
What to do: Standard pairing. Watch for additive GI side effects in the first 2 weeks; staggering doses 4+ hours apart helps. No dose adjustment needed.
Ozempicsemaglutide
No documented interaction
Mechanism: Distinct mechanisms (metformin: hepatic glucose production + insulin sensitivity; GLP-1: glucose-dependent insulin secretion + satiety).
What to do: Standard pairing. Watch for additive GI side effects in the first 2 weeks; staggering doses 4+ hours apart helps. No dose adjustment needed.
Mounjarotirzepatide
No documented interaction
Mechanism: Distinct mechanisms (metformin: hepatic glucose production + insulin sensitivity; GLP-1: glucose-dependent insulin secretion + satiety).
What to do: Standard pairing. Watch for additive GI side effects in the first 2 weeks; staggering doses 4+ hours apart helps. No dose adjustment needed.
Foundayoorforglipron
No documented interaction
Mechanism: Distinct mechanisms (metformin: hepatic glucose production + insulin sensitivity; GLP-1: glucose-dependent insulin secretion + satiety).
What to do: Standard pairing. Watch for additive GI side effects in the first 2 weeks; staggering doses 4+ hours apart helps. No dose adjustment needed.

Sources

ADA Standards of Care 2024 — combination therapy (opens in a new tab) — American Diabetes Association

See other interactions

Full interaction index